|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
10.860 +0.040 (+0.370%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 5,827,258 | 5,231,520 | 4,743,361 | 5,061,326 | 6,844,721 |
| Net Cash from / (used in) Investing Activities | 415,980 | (2,491,873) | (12,473,124) | (6,015,576) | (1,705,676) |
| Net Cash from / (used in) Financing Activities | (1,863,930) | 231,851 | 12,138,594 | 1,565,628 | (1,261,230) |
| Increase / (Decrease) in Cash & Cash Equivalents | 4,379,307 | 2,971,498 | 4,408,831 | 611,379 | 3,877,814 |
| Cash & Cash Equivalents at beginning of period | 27,499,809 | 24,533,891 | 20,137,500 | 19,576,445 | 15,716,258 |
| Effect of Foreign Exchange Rate Changes | 2,157 | (5,580) | (12,440) | (50,323) | (17,628) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 31,881,273 | 27,499,809 | 24,533,891 | 20,137,500 | 19,576,445 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,552,528 |
| %Change | 20.821% |
| EPS / (LPS) | RMB 1.230 |
| NBV Per Share (¥) | RMB 25.700 |